002422 科伦药业
已收盘 09-11 15:00:00
资讯
新帖
简况
瑞银：中国制药股上半年业绩好坏参半 首选先声药业
同花顺 · 09-09
瑞银：中国制药股上半年业绩好坏参半 首选先声药业
东海证券：给予科伦药业买入评级
证券之星 · 09-08
东海证券：给予科伦药业买入评级
科伦药业新注册《科伦药业员工电子档案系统1.0》项目的软件著作权
证券之星 · 09-08
科伦药业新注册《科伦药业员工电子档案系统1.0》项目的软件著作权
摩根士丹利将科伦药业评级上调至超配，目标价61元。
格隆汇 · 09-03
摩根士丹利将科伦药业评级上调至超配，目标价61元。
科伦药业新注册《科伦药业SAP仓库管理移动终端系统V3.0》项目的软件著作权
证券之星 · 09-03
科伦药业新注册《科伦药业SAP仓库管理移动终端系统V3.0》项目的软件著作权
科伦药业（002422）披露回购公司股份进展公告，9月1日股价上涨0.62%
证券之星 · 09-01
科伦药业（002422）披露回购公司股份进展公告，9月1日股价上涨0.62%
科伦药业（002422）股东刘革新质押882万股，占总股本0.56%
证券之星 · 09-01
科伦药业（002422）股东刘革新质押882万股，占总股本0.56%
股市必读：科伦药业新发布《关于公司控股股东部分股份质押及解除质押的公告》
证券之星 · 08-31
股市必读：科伦药业新发布《关于公司控股股东部分股份质押及解除质押的公告》
科伦药业（002422）股东刘革新质押1429万股，占总股本0.9%
证券之星 · 08-29
科伦药业（002422）股东刘革新质押1429万股，占总股本0.9%
科伦药业：东北证券、汇添富基金等多家机构于8月27日调研我司
证券之星 · 08-28
科伦药业：东北证券、汇添富基金等多家机构于8月27日调研我司
科伦药业（002422）披露控股股东部分股份质押及解除质押公告，8月28日股价下跌1.25%
证券之星 · 08-28
科伦药业（002422）披露控股股东部分股份质押及解除质押公告，8月28日股价下跌1.25%
科伦药业（002422）2026年中报简析：净利润同比增长12.71%
证券之星 · 08-28
科伦药业（002422）2026年中报简析：净利润同比增长12.71%
股市必读：科伦药业新发布《关于“质量回报双提升”行动方案的进展公告》
证券之星 · 08-27
股市必读：科伦药业新发布《关于“质量回报双提升”行动方案的进展公告》
科伦药业最新公告：上半年净利润11.28亿元同比增长12.71%
证券之星 · 08-26
科伦药业最新公告：上半年净利润11.28亿元同比增长12.71%
药企“老板营销”潮起：辉瑞总裁晒减重，科伦董事长秀肌肉，行业竞争白热化，销量增长陷疲态
华夏时报网 · 08-22
药企“老板营销”潮起：辉瑞总裁晒减重，科伦董事长秀肌肉，行业竞争白热化，销量增长陷疲态
科伦博泰生物中期业绩亮眼：归母净利润达3.88亿元人民币
投资观察 · 08-17
科伦博泰生物中期业绩亮眼：归母净利润达3.88亿元人民币
科伦药业新注册《科伦药业CRM客户管理系统1.0》项目的软件著作权
证券之星 · 08-11
科伦药业新注册《科伦药业CRM客户管理系统1.0》项目的软件著作权
科伦药业新注册《科伦药业文献管理系统1.0》项目的软件著作权
证券之星 · 08-08
科伦药业新注册《科伦药业文献管理系统1.0》项目的软件著作权
股市必读：科伦药业新发布《关于公司控股股东部分股份质押及解除质押的公告》
证券之星 · 08-06
股市必读：科伦药业新发布《关于公司控股股东部分股份质押及解除质押的公告》
科伦药业（002422）披露回购公司股份进展公告，8月4日股价上涨2.32%
证券之星 · 08-04
科伦药业（002422）披露回购公司股份进展公告，8月4日股价上涨2.32%
暂无数据
公司概况
公司名称：
四川科伦药业股份有限公司
所属行业：
医药制造业
上市日期：
2010-06-03
主营业务：
四川科伦药业股份有限公司的主营业务是大容量注射剂（输液）、小容量注射剂（水针）、注射用无菌粉针（含分装粉针及冻干粉针）、片剂、胶囊剂、颗粒剂、口服液、腹膜透析液等27种剂型药品及中间体、原料药、医药包材等产品的研发、生产和销售。公司的主要产品是大容量注射剂（输液）、小容量注射剂（水针）、注射用无菌粉针（含分装粉针及冻干粉针）、片剂、胶囊剂、颗粒剂、口服液、腹膜透析液。公司位列“中国医药制造业百强”和“中国制造业500强”，荣登“中国化药企业百强”和“BigPharma企业创新力十强”等榜单。
发行价格：
83.36
{"stockData":{"symbol":"002422","market":"SZ","secType":"STK","nameCN":"科伦药业","latestPrice":39.35,"timestamp":1789110234000,"preClose":40.14,"halted":0,"volume":11729881,"delay":0,"changeRate":-0.0197,"floatShares":1299000000,"shares":1591000000,"eps":1.1498,"marketStatus":"已收盘","change":-0.79,"latestTime":"09-11 15:00:00","open":39.81,"high":40.06,"low":38.96,"amount":461000000,"amplitude":0.0274,"askPrice":39.35,"askSize":230,"bidPrice":39.34,"bidSize":62,"shortable":0,"etf":0,"ttmEps":1.1498,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1789349400000},"marketStatusCode":5,"adr":0,"adjPreClose":40.14,"symbolType":"stock","openAndCloseTimeList":[[1789090200000,1789097400000],[1789102800000,1789110000000]],"highLimit":44.15,"lowLimit":36.13,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1590781208,"isCdr":false,"pbRate":2.59,"roa":"--","peRate":34.223343,"roe":"4.59%","epsLYR":1.07,"committee":-0.255854,"marketValue":62597000000,"turnoverRate":0.009,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-09-14。","floatMarketCap":51098000000},"requestUrl":"/m/hq/s/002422/tweets","defaultTab":"tweets","newsList":[{"id":"2666831405","title":"瑞银：中国制药股上半年业绩好坏参半 首选先声药业","url":"https://stock-news.laohu8.com/highlight/detail?id=2666831405","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666831405?lang=zh_cn&edition=full","pubTime":"2026-09-09 15:58","pubTimestamp":1788940680,"startTime":"0","endTime":"0","summary":"瑞银发布研报称，中国制药股上半年业绩好坏参半，在九家评级的制药公司中，有五家业绩好过市场预期，分别为翰森制药(03692)、先声药业(02096)、中国生物制药(01177)、石药集团(01093)及科伦 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun","url":"http://stock.10jqka.com.cn/hks/20260909/c679739404.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20260909/c679739404.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["002422","BK0187","LU2148510915.USD","LU2328871848.SGD","LU1979443071.USD","BK0060","BK0209","BK0239","BK0183","BK0188","000963","LU1064130708.USD","LU1934453819.USD","BK0196","BK0132","LU1064131003.USD","LU1969619763.USD","BK0175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665228583","title":"东海证券：给予科伦药业买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2665228583","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665228583?lang=zh_cn&edition=full","pubTime":"2026-09-08 18:51","pubTimestamp":1788864708,"startTime":"0","endTime":"0","summary":"东海证券股份有限公司杜永宏近期对科伦药业进行研究并发布了研究报告《公司简评报告：收入端逐渐企稳，创新药快速放量》，给予科伦药业买入评级。公司大输液结构持续优化，创新药快速放量，维持“买入”评级。最新盈利预测明细如下：该股最近90天内共有8家机构给出评级，买入评级7家，中性评级1家；过去90天内机构目标均价为45.93。本文数据来源于东海证券股份有限公司，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090800029565.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","002422"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665331094","title":"科伦药业新注册《科伦药业员工电子档案系统1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2665331094","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665331094?lang=zh_cn&edition=full","pubTime":"2026-09-08 02:15","pubTimestamp":1788804916,"startTime":"0","endTime":"0","summary":"证券之星消息，近日科伦药业（002422）新注册了《科伦药业员工电子档案系统1.0》项目的软件著作权。今年以来科伦药业新注册软件著作权4个。结合公司2026年中报财务数据，今年上半年公司在研发方面投入了12.13亿元，同比增15.69%。通过天眼查大数据分析，四川科伦药业股份有限公司共对外投资了47家企业，参与招投标项目8384次；财产线索方面有商标信息1209条，专利信息2081条，著作权信息19条；此外企业还拥有行政许可1370个。数据来源：天眼查APP以上内容为证券之星据公开信息整理，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090800000691.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002422","LU1934453819.USD","LU2148510915.USD","159180","BK0060","LU1064131003.USD","BK0239","LU1979443071.USD","LU1064130708.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664827136","title":"摩根士丹利将科伦药业评级上调至超配，目标价61元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2664827136","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664827136?lang=zh_cn&edition=full","pubTime":"2026-09-03 16:17","pubTimestamp":1788423429,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU1064130708.USD","002422","LU1979443071.USD","BK0239","LU1064131003.USD","LU1934453819.USD","LU2148510915.USD","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664284541","title":"科伦药业新注册《科伦药业SAP仓库管理移动终端系统V3.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2664284541","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664284541?lang=zh_cn&edition=full","pubTime":"2026-09-03 02:16","pubTimestamp":1788372974,"startTime":"0","endTime":"0","summary":"证券之星消息，近日科伦药业（002422）新注册了《科伦药业SAP仓库管理移动终端系统V3.0》项目的软件著作权。今年以来科伦药业新注册软件著作权3个。结合公司2026年中报财务数据，今年上半年公司在研发方面投入了12.13亿元，同比增15.69%。通过天眼查大数据分析，四川科伦药业股份有限公司共对外投资了47家企业，参与招投标项目8380次；财产线索方面有商标信息1209条，专利信息2081条，著作权信息18条；此外企业还拥有行政许可1368个。数据来源：天眼查APP以上内容为证券之星据公开信息整理，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300002026.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","LU1064131003.USD","LU2148510915.USD","BK0060","159180","002422","LU1934453819.USD","LU1064130708.USD","LU1979443071.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664852919","title":"科伦药业（002422）披露回购公司股份进展公告，9月1日股价上涨0.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664852919","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664852919?lang=zh_cn&edition=full","pubTime":"2026-09-01 22:08","pubTimestamp":1788271717,"startTime":"0","endTime":"0","summary":"截至2026年9月1日收盘，科伦药业报收于40.83元，较前一交易日上涨0.62%，最新总市值为649.52亿元。该股当日开盘40.7元，最高41.1元，最低40.05元，成交额达7.37亿元，换手率为1.4%。近日，科伦药业发布《关于回购公司股份进展的公告》。本次回购符合相关法律法规及既定方案。公司后续将根据市场情况继续实施回购，并履行信息披露义务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100042409.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1064131003.USD","002422","LU1979443071.USD","BK0060","BK0239","LU1064130708.USD","LU1934453819.USD","LU2148510915.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664858700","title":"科伦药业（002422）股东刘革新质押882万股，占总股本0.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664858700","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664858700?lang=zh_cn&edition=full","pubTime":"2026-09-01 18:27","pubTimestamp":1788258455,"startTime":"0","endTime":"0","summary":"证券之星消息，科伦药业9月1日公开信息显示，股东刘革新向华泰证券(上海)资产管理有限公司合计质押882.0万股，占总股本0.56%。质押详情见下表：截止本公告日，股东刘革新已累计质押股份8463.0万股，占其持股总数的22.32%，股东雅安市国有资产经营有限责任公司已累计质押股份3089.0万股，占其持股总数的32.93%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100034937.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","LU1064131003.USD","LU2148510915.USD","LU1979443071.USD","BK0239","LU1934453819.USD","LU1064130708.USD","002422"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663804257","title":"股市必读：科伦药业新发布《关于公司控股股东部分股份质押及解除质押的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2663804257","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663804257?lang=zh_cn&edition=full","pubTime":"2026-08-31 01:15","pubTimestamp":1788110110,"startTime":"0","endTime":"0","summary":"公司公告汇总：控股股东刘革新先生解除质押1500万股、新质押1429万股，累计质押股份占其所持股份比例为23.29%，无平仓风险，不导致实际控制人变更。公司公告汇总关于公司控股股东部分股份质押及解除质押的公告四川科伦药业股份有限公司控股股东刘革新先生近日办理部分股份解除质押及新质押业务：本次解除质押15,000,000股，占其所持股份比例3.96%，占公司总股本0.94%；同时新质押14,290,000股，占其所持股份3.77%，占公司总股本0.90%，质押用途为个人资金需求。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100000576.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0239","LU1064131003.USD","002422","LU1934453819.USD","LU2148510915.USD","LU1064130708.USD","LU1979443071.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663901330","title":"科伦药业（002422）股东刘革新质押1429万股，占总股本0.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663901330","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663901330?lang=zh_cn&edition=full","pubTime":"2026-08-29 00:21","pubTimestamp":1787934096,"startTime":"0","endTime":"0","summary":"证券之星消息，科伦药业8月29日公开信息显示，股东刘革新向华泰证券(上海)资产管理有限公司合计质押1429.0万股，占总股本0.9%。质押详情见下表：截止本公告日，股东刘革新已累计质押股份8831.0万股，占其持股总数的23.29%，股东雅安市国有资产经营有限责任公司已累计质押股份3089.0万股，占其持股总数的32.93%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082900001047.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1064131003.USD","LU1934453819.USD","BK0239","LU2148510915.USD","BK0060","LU1064130708.USD","002422","LU1979443071.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662099767","title":"科伦药业：东北证券、汇添富基金等多家机构于8月27日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2662099767","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662099767?lang=zh_cn&edition=full","pubTime":"2026-08-28 22:20","pubTimestamp":1787926835,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年8月28日科伦药业发布公告称东北证券、汇添富基金、华创证券、华泰证券、华西证券、嘉实基金、开源证券、摩根士丹利、南方基金、申万宏源、UBS、东方财富、西部证券、西南证券、银河证券、浙商证券、中金公司、中泰证券、中信建投、中信证券、中国平安、东方证券、东吴证券、方正证券、富国基金、广发证券、国联民生证券、国泰海通于2026年8月27日调研我司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800054634.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0183","LU1934453819.USD","002422","000686","LU1064131003.USD","BK0028","LU1979443071.USD","LU2148510915.USD","BK0188","BK0276","LU1064130708.USD","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662099855","title":"科伦药业（002422）披露控股股东部分股份质押及解除质押公告，8月28日股价下跌1.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662099855","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662099855?lang=zh_cn&edition=full","pubTime":"2026-08-28 22:03","pubTimestamp":1787925796,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，科伦药业报收于41.75元，较前一交易日下跌1.25%，最新总市值为664.15亿元。该股当日开盘42.0元，最高42.31元，最低41.54元，成交额达7.21亿元，换手率为1.33%。公告显示，公司控股股东刘革新先生近日办理了部分股份解除质押及新质押业务。本次质押后，刘革新先生累计质押股份占其所持股份比例为23.29%。相关股份不存在业绩补偿义务，亦未出现平仓风险。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800053443.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","LU1064131003.USD","LU1934453819.USD","BK0239","LU2148510915.USD","LU1979443071.USD","002422","LU1064130708.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662396660","title":"科伦药业（002422）2026年中报简析：净利润同比增长12.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662396660","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662396660?lang=zh_cn&edition=full","pubTime":"2026-08-28 06:27","pubTimestamp":1787869674,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期科伦药业发布2026年中报。根据财报显示，科伦药业净利润同比增长12.71%。截至本报告期末，公司营业总收入88.39亿元，同比下降2.69%，归母净利润11.28亿元，同比上升12.71%。按单季度数据看，第二季度营业总收入45.79亿元，同比下降2.43%，第二季度归母净利润6.74亿元，同比上升61.89%。去年的净利率为10.14%，算上全部成本后，公司产品或服务的附加值一般。本文数据来源于科伦药业2026年中报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800011398.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002422"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662746372","title":"股市必读：科伦药业新发布《关于“质量回报双提升”行动方案的进展公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2662746372","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662746372?lang=zh_cn&edition=full","pubTime":"2026-08-27 01:06","pubTimestamp":1787763983,"startTime":"0","endTime":"0","summary":"公司公告汇总关于“质量回报双提升”行动方案的进展公告科伦药业披露“质量回报双提升”行动方案2026年上半年实施进展。关于变更公司会计政策的公告四川科伦药业股份有限公司根据财政部发布的《企业会计准则解释第19号》和《企业会计准则解释第20号》相关规定，对会计政策进行变更。2026年半年度非经营性资金占用及其他关联资金往来情况汇总表四川科伦药业股份有限公司披露2026年半年度非经营性资金占用及其他关联资金往来情况汇总表。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700003277.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1979443071.USD","LU1064130708.USD","LU2148510915.USD","BK0239","BK0060","LU1064131003.USD","LU1934453819.USD","002422"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662171588","title":"科伦药业最新公告：上半年净利润11.28亿元同比增长12.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662171588","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662171588?lang=zh_cn&edition=full","pubTime":"2026-08-26 19:17","pubTimestamp":1787743051,"startTime":"0","endTime":"0","summary":"科伦药业(002422.SZ)公告称，公司发布2026年半年度报告，实现营业收入88.39亿元，同比下降2.7%；归属于上市公司股东的净利润11.28亿元，同比增长12.71%。公司拟每10股派发现金红利1.26元(含税)。注：公司Q2净利润6.74亿，Q1净利润4.54亿，据此计算，Q2净利润环比增长48%。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600043355.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002422"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661521932","title":"药企“老板营销”潮起：辉瑞总裁晒减重，科伦董事长秀肌肉，行业竞争白热化，销量增长陷疲态","url":"https://stock-news.laohu8.com/highlight/detail?id=2661521932","media":"华夏时报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661521932?lang=zh_cn&edition=full","pubTime":"2026-08-22 18:53","pubTimestamp":1787396024,"startTime":"0","endTime":"0","summary":"雷军打响了企业家带货第一枪，如今这股热潮已蔓延至医药圈。近日，辉瑞中国区总裁彭振科（Jean-ChristophePointeau）分享的个人减重经历视频，在医药行业内引发热议。这位法国高管展示了自己四个月内体重从104公斤降至87公斤的变化，并提及“正在使用辉瑞减重药物”，配合健康生活方式取得效果。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608223850183557.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608223850183557.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IE00B19Z3581.USD","LU1057294990.SGD","PFE","IE00B19Z3B42.SGD","LU1066053197.SGD","BK4581","BK4592","LU0225771236.USD","LU0225284248.USD","LU1064131003.USD","LU1979443071.USD","IE00BLSP4452.SGD","LU1894683348.USD","LU0122379950.USD","LU1066051498.USD","SG9999003800.SGD","SG9999002224.SGD","BK0239","BK4550","LU1934453819.USD","BK4588","LU0234572021.USD","LU1064130708.USD","IE000M9KFDE8.USD","SG9999001176.SGD","BK4533","LU1023059063.AUD","LU0058720904.USD","LU0868494617.USD","LU0306806265.USD","LU0306807586.USD","LU0321505439.SGD","BK0060","SG9999001176.USD","LU0289739699.SGD","LU1883839398.USD","SGXZ57979304.SGD","IE00BBT3K403.USD","BK4007","LU2148510915.USD","LU0321505868.SGD","002422","LU2596442595.SGD","SG9999013999.USD","LU1894683264.USD","SG9999002232.USD","IE00B3T34201.USD","BK4568","LU0456855351.SGD","LU0985481810.HKD","BK4534","BK4585","OZEM","SG9999011175.SGD","IE00BLSP4239.USD","IE0002270589.USD","BK4599","LU0170899867.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136932387","title":"科伦博泰生物中期业绩亮眼：归母净利润达3.88亿元人民币","url":"https://stock-news.laohu8.com/highlight/detail?id=1136932387","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1136932387?lang=zh_cn&edition=full","pubTime":"2026-08-17 19:27","pubTimestamp":1786966033,"startTime":"0","endTime":"0","summary":"8月17日，据路透社报道，四川科伦博泰生物医药股份有限公司（简称“科伦博泰生物”）公布其上半年财务表现。数据显示，该公司报告期内归属于母公司股东的净利润达到3.88亿元人民币，彰显出强劲的盈利增长势头。这一业绩成果不仅反映了公司在生物医药领域的深耕成效，也为其未来发展奠定了坚实基础。作为科伦药业（002422）旗下的重要生物制药平台，科伦博泰生物（06990）凭借持续的技术创新与产品管线拓展，正稳步提升市场竞争力。此次中期业绩的公布，无疑为投资者提供了积极信号，进一步巩固了市场对其长期价值的信心。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","LU2148510915.USD","LU1934453819.USD","LU0196878994.USD","06990","002422","LU1064131003.USD","LU1979443071.USD","LU1064130708.USD","BK1161","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658195569","title":"科伦药业新注册《科伦药业CRM客户管理系统1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2658195569","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658195569?lang=zh_cn&edition=full","pubTime":"2026-08-11 02:22","pubTimestamp":1786386132,"startTime":"0","endTime":"0","summary":"证券之星消息，近日科伦药业（002422）新注册了《科伦药业CRM客户管理系统1.0》项目的软件著作权。今年以来科伦药业新注册软件著作权2个。结合公司2025年年报财务数据，2025年公司在研发方面投入了22.05亿元，同比增1.6%。通过天眼查大数据分析，四川科伦药业股份有限公司共对外投资了47家企业，参与招投标项目8817次；财产线索方面有商标信息1206条，专利信息2081条，著作权信息16条；此外企业还拥有行政许可1368个。数据来源：天眼查APP以上内容为证券之星据公开信息整理，不构成投资建议。相关 ETF","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100001867.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0239","002422","LU1064131003.USD","LU1934453819.USD","LU2148510915.USD","159180","LU1064130708.USD","LU1979443071.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657233566","title":"科伦药业新注册《科伦药业文献管理系统1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2657233566","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657233566?lang=zh_cn&edition=full","pubTime":"2026-08-08 02:23","pubTimestamp":1786126990,"startTime":"0","endTime":"0","summary":"证券之星消息，近日科伦药业（002422）新注册了《科伦药业文献管理系统1.0》项目的软件著作权。今年以来科伦药业新注册软件著作权1个。结合公司2025年年报财务数据，2025年公司在研发方面投入了22.05亿元，同比增1.6%。通过天眼查大数据分析，四川科伦药业股份有限公司共对外投资了47家企业，参与招投标项目8817次；财产线索方面有商标信息1206条，专利信息2081条，著作权信息16条；此外企业还拥有行政许可1368个。数据来源：天眼查APP以上内容为证券之星据公开信息整理，不构成投资建议。相关 ETF","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080800001147.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002422","LU1064130708.USD","LU2148510915.USD","LU1934453819.USD","159180","BK0239","LU1064131003.USD","BK0060","LU1979443071.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657212995","title":"股市必读：科伦药业新发布《关于公司控股股东部分股份质押及解除质押的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2657212995","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657212995?lang=zh_cn&edition=full","pubTime":"2026-08-06 01:45","pubTimestamp":1785951916,"startTime":"0","endTime":"0","summary":"截至2026年8月5日收盘，科伦药业报收于42.9元，上涨1.44%，换手率1.97%，成交量25.62万手，成交额10.99亿元。公司公告汇总关于公司控股股东部分股份质押及解除质押的公告四川科伦药业股份有限公司控股股东刘革新先生近日办理了部分股份解除质押及新质押业务。本次解除质押9,167,000股，占其所持股份比例2.42%，占公司总股本0.58%；同时新质押6,900,000股，占其所持股份比例1.82%，占公司总股本0.43%，质押用途为个人资金需求。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080600001612.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002422","LU1934453819.USD","LU1979443071.USD","LU1064130708.USD","LU2148510915.USD","BK0060","LU1064131003.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656053119","title":"科伦药业（002422）披露回购公司股份进展公告，8月4日股价上涨2.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656053119","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656053119?lang=zh_cn&edition=full","pubTime":"2026-08-04 17:47","pubTimestamp":1785836863,"startTime":"0","endTime":"0","summary":"截至2026年8月4日收盘，科伦药业报收于42.29元，较前一交易日上涨2.32%，最新总市值为672.74亿元。该股当日开盘42.0元，最高42.97元，最低41.66元，成交额达11.28亿元，换手率为2.05%。科伦药业于2026年8月4日披露《关于回购公司股份进展的公告》。本次回购符合相关法规及既定方案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080400029712.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1064130708.USD","LU2148510915.USD","LU1934453819.USD","BK0060","LU1064131003.USD","LU1979443071.USD","BK0239","002422"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1789247671722,"stockEarnings":[{"period":"1week","weight":-0.0613},{"period":"1month","weight":-0.1612},{"period":"3month","weight":0.0547},{"period":"6month","weight":0.2244},{"period":"1year","weight":0.0782},{"period":"ytd","weight":0.3596}],"compareEarnings":[{"period":"1week","weight":-0.0107},{"period":"1month","weight":-0.0148},{"period":"3month","weight":-0.0356},{"period":"6month","weight":-0.0506},{"period":"1year","weight":0.0033},{"period":"ytd","weight":-0.0203}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"四川科伦药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"38356人(较上一季度减少6.56%)","perCapita":"33855股","listingDate":"2010-06-03","address":"四川省成都市新都区新都卫星城工业开发区南二路","registeredCapital":"159078万元","survey":" 四川科伦药业股份有限公司的主营业务是大容量注射剂（输液）、小容量注射剂（水针）、注射用无菌粉针（含分装粉针及冻干粉针）、片剂、胶囊剂、颗粒剂、口服液、腹膜透析液等27种剂型药品及中间体、原料药、医药包材等产品的研发、生产和销售。公司的主要产品是大容量注射剂（输液）、小容量注射剂（水针）、注射用无菌粉针（含分装粉针及冻干粉针）、片剂、胶囊剂、颗粒剂、口服液、腹膜透析液。公司位列“中国医药制造业百强”和“中国制造业500强”，荣登“中国化药企业百强”和“BigPharma企业创新力十强”等榜单。","listedPrice":83.36},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"科伦药业(002422)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供科伦药业(002422)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"科伦药业,002422,科伦药业股票,科伦药业股票老虎,科伦药业股票老虎国际,科伦药业行情,科伦药业股票行情,科伦药业股价,科伦药业股市,科伦药业股票价格,科伦药业股票交易,科伦药业股票购买,科伦药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"科伦药业(002422)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供科伦药业(002422)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}